-- Alteogen (KOSDAQ:196170) posted first-quarter net income attributable to shareholders of 71.7 billion won, down 14% from 83.2 billion won a year earlier, according to a Friday filing with the Korea Exchange.
Sales of the South Korean pharmaceutical firm fell 15% year over year to 71.6 billion won from 83.7 billion won.
Shares of Alteogen fell over 4% at market close.